Beijing Airdoc Proposes Reallocation of IPO Proceeds
Company Announcements

Beijing Airdoc Proposes Reallocation of IPO Proceeds

Beijing Airdoc Technology Co. Ltd. Class H (HK:2251) has released an update.

Beijing Airdoc Technology Co., Ltd. is proposing a change in the allocation of the unutilized HK$723.7 million from its Global Offering proceeds, to be discussed in the 2024 first extraordinary general meeting. About 51.6% of the proceeds from the Global Offering have been utilized as of June 30, 2024, with the remainder set for reallocation according to the company’s updated R&D progress, operation levels, and business strategies. The funds are earmarked for further development and commercialization of its core products, with full utilization expected by 2026.

For further insights into HK:2251 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App